Vonderheid EC - Search Results

1

IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.

Rook AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Wolf SF, Singh A, Trinchieri G, Lessin SR. Rook AH, et al. Among authors: vonderheid ec. J Immunol. 1995 Feb 1;154(3):1491-8. J Immunol. 1995. PMID: 7822812

2

The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma.

Rook AH, Kubin M, Fox FE, Niu Z, Cassin M, Vowels BR, Gottleib SL, Vonderheid EC, Lessin SR, Trinchieri G. Rook AH, et al. Among authors: vonderheid ec. Ann N Y Acad Sci. 1996 Oct 31;795:310-8. doi: 10.1111/j.1749-6632.1996.tb52680.x. Ann N Y Acad Sci. 1996. PMID: 8958942

3

Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12.

Suchin KR, Cassin M, Gottleib SL, Sood S, Cucchiara AJ, Vonderheid EC, Rook AH. Suchin KR, et al. Among authors: vonderheid ec. J Am Acad Dermatol. 2001 Jan;44(1):28-32. doi: 10.1067/mjd.2001.109853. J Am Acad Dermatol. 2001. PMID: 11148473

4

Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.

Vowels BR, Cassin M, Vonderheid EC, Rook AH. Vowels BR, et al. Among authors: vonderheid ec. J Invest Dermatol. 1992 Jul;99(1):90-4. doi: 10.1111/1523-1747.ep12611877. J Invest Dermatol. 1992. PMID: 1607682 Free article.

5

Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndrome.

Abrams JT, Lessin SR, Ghosh SK, Nowell PC, Ju W, Vonderheid EC, Rook AH, DeFreitas E. Abrams JT, et al. Among authors: vonderheid ec. J Immunol. 1991 Mar 1;146(5):1455-62. J Immunol. 1991. PMID: 1847162

6

Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.

Kasprzycka M, Zhang Q, Witkiewicz A, Marzec M, Potoczek M, Liu X, Wang HY, Milone M, Basu S, Mauger J, Choi JK, Abrams JT, Hou JS, Rook AH, Vonderheid E, Woetmann A, Odum N, Wasik MA. Kasprzycka M, et al. J Immunol. 2008 Aug 15;181(4):2506-12. doi: 10.4049/jimmunol.181.4.2506. J Immunol. 2008. PMID: 18684941 Free PMC article.

7

Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients.

Capocasale RJ, Lamb RJ, Vonderheid EC, Fox FE, Rook AH, Nowell PC, Moore JS. Capocasale RJ, et al. Among authors: vonderheid ec. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5501-5. doi: 10.1073/pnas.92.12.5501. Proc Natl Acad Sci U S A. 1995. PMID: 7777538 Free PMC article.

8

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.

Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA. Zhang Q, et al. Among authors: vonderheid ec. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9148-53. doi: 10.1073/pnas.93.17.9148. Proc Natl Acad Sci U S A. 1996. PMID: 8799169 Free PMC article.

9

Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.

Rook AH, Wood GS, Yoo EK, Elenitsas R, Kao DM, Sherman ML, Witmer WK, Rockwell KA, Shane RB, Lessin SR, Vonderheid EC. Rook AH, et al. Among authors: vonderheid ec. Blood. 1999 Aug 1;94(3):902-8. Blood. 1999. PMID: 10419880 Free article. Clinical Trial.

10

Mycosis fungoides with CD30-positive cells in the epidermis.

Wu H, Telang GH, Lessin SR, Vonderheid EC. Wu H, et al. Among authors: vonderheid ec. Am J Dermatopathol. 2000 Jun;22(3):212-6. doi: 10.1097/00000372-200006000-00002. Am J Dermatopathol. 2000. PMID: 10871063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters